UBS O'Connor’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Buy |
+26,000
| New | +$676K | 0.03% | 233 |
|
|
2025
Q1 | – | Sell |
-12,834
| Closed | -$368K | – | 305 |
|
|
2024
Q4 | $368K | Buy |
12,834
+1,810
| +16% | +$51.9K | 0.01% | 286 |
|
|
2024
Q3 | $416K | Buy |
11,024
+1,024
| +10% | +$38.6K | 0.01% | 340 |
|
|
2024
Q2 | $316K | Buy |
+10,000
| New | +$316K | 0.01% | 378 |
|